Ads
related to: dementia treatment drugsdementiasociety.org has been visited by 10K+ users in the past month
alternativebee.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
They stress that the repurposing of existing drugs for possible dementia treatment is a global priority, but experts say that more studies need to be conducted to establish concrete effects of ...
A recent study found that a class of medications called SGLT-2 inhibitors—which does not include Ozempic or similar drugs like Zepbound—significantly lowered the risk of dementia in people ...
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in ...
A dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug has been found to reduce memory decline among patients with early-stage disease.
[8] [12] Memantine was first studied in the treatment of Alzheimer's disease in 1986. [13] [14] The drug was first marketed for dementia in 1989 in Germany under the name Axura. [8] [14] [12] It was not discovered to act as an NMDA receptor antagonist until 1989, after clinical trials had initiated.
The clinical guidelines for medication management in people with dementia recommend trialing an AChE inhibitor for people with early- to mid-stage dementia. These guidelines, known as the Medication Appropriateness Tool for Comorbid Health conditions in Dementia (MATCH-D), suggest that these medicines are at least considered.
Ads
related to: dementia treatment drugsdementiasociety.org has been visited by 10K+ users in the past month
alternativebee.com has been visited by 10K+ users in the past month